Drug Discovery companies

Achira develops atomistic foundation simulation models combining machine learning and physics-based methods to advance drug discovery.

Absentia Labs builds AI foundation models from biological and clinical data to predict drug behavior and accelerate pharmaceutical development.

Matterworks, Inc. builds AI-powered tools for extracting insights from biological data to support therapeutic discovery, drug development, and biomanufacturing.

PANTHERx Rare is the largest independent US rare disease pharmacy, operating a technology-driven care model licensed across all 50 states.

N-Power Medicine develops an AI-powered clinical research system for community oncology to increase trial participation and speed up drug development.

Nomic develops high-throughput proteomics platforms, including the nELISA and Omni 1000 systems, for large-scale quantitative protein profiling in pharmaceutica…

Sumitomo Pharma is a pharmaceutical company developing treatments in oncology, CNS disorders, and regenerative medicine, integrating AI and machine learning int…

Alkermes is a biopharmaceutical company developing and commercializing medicines for psychiatric and neurological disorders, including addiction, serious mental…